Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A11DB	NEURORUBINE	G	Vitamin B12 - 1mg, Vitamin B6 - 100mg, Vitamin B1 - 100mg		Injectable solution	302,365 L.L
B05XA03	CHLORURE DE SODIUM 0.9 pour cent Renaudin	G	Sodium chloride - 0.9%	0.9%	Injectable solution	385,683 L.L
C07AB03	ATONIUM	G	Atenolol - 100mg	100mg	Tablet	461,207 L.L
C09DA03	CO-ANGINET	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	544,256 L.L
C10AC01	RESINCOLESTIRAMINA	G	Cholestyramine - 4g	4g	Powder for suspension	2,998,113 L.L
D11AX01	HAIRGROW	G	Minoxidil - 5%	5%	Solution	1,061,636 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
J01XD02	PROTOGYN	G	Tinidazole - 500mg	500mg	Tablet, film coated	223,078 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
N05AH03	OLANZAMED	G	Olanzapine - 20mg	20mg	Tablet	3,941,938 L.L
N06BX03	CEBROTONIN	G	Piracetam - 800mg	800mg	Tablet, film coated	577,852 L.L
R03BB04	NEUMOTROPIO	G	Tiotropium bromide - 10mcg	10mcg	Capsule, inhalation	2,997,155 L.L
A02BC05	ESOMEPRAZOLE NORMON	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	430,030 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	1,104,639 L.L
C07AB03	BLOKIUM 100MG	G	Atenolol - 100mg	100mg	Tablet	377,620 L.L
C09DA03	CO-TABUVAN	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	544,256 L.L
D11AX01	MINOXIDIL BAILLEUL	G	Minoxidil - 5%	5%	Solution	3,675,409 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	508,100 L.L
J01XE01	NITROFURANTOIN	G	Nitrofurantoin - 100mg	100mg	Tablet	972,942 L.L
M02AA15	VOLDIC	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Emulgel	172,012 L.L
N02BE01	PARACEROL	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	1,536,012 L.L
N06BX06	CEROLINE	G	Citicoline - 100mg/ml	100mg/ml	Solution	894,615 L.L
A02BC05	ESSIUM	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	314,459 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	705,517 L.L
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 400mg	400mg	Tablet, coated	615,480 L.L
C09DA03	VALUSTAR PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	592,635 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
J01XE01	UVAMIN RETARD	G	Nitrofurantoin (macrocrystals) - 100mg	100mg	Capsule	392,402 L.L
N02BE01	PARA-SOLUTIONS	G	Paracetamol - 1g/100ml	500mg/100ml	Injectable solution	179,179 L.L
N06BX06	TRAUSAN	G	Citicoline - 100mg/ml	100mg/ml	Drops solution	807,649 L.L